Clinical Trial Update: Combination of Efavirenz and Truvada - COMET Study [Phase 4]

View source ↗

Summary

Phase 4 COMET trial evaluating the combination of efavirenz and Truvada for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Sustiva (efavirenz)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED